Skip to main content

Advertisement

Log in

Lack of effect of antipsychotics on BNDF and NGF levels in hippocampus of Wistar rats

  • Original Paper
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Schizophrenia is a common and serious mental disorder, in which the majority of patients require long-term antipsychotic treatment. Several studies have suggested that schizophrenia is associated with decreased neurotrophins such as brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF). Investigation of the mechanisms of pharmacological agents that are used in the treatment of schizophrenia has been used to better understand the basis of the pathology associated with this mental illness. The present study aims to investigate the effect of chronic treatment with antipsychotics, named haloperidol (HAL), clozapine (CLO), olanzapine (OLZ) or aripiprazole (ARI) on BDNF and NGF levels in rat hippocampus. Adult male Wistar rats received daily injections of HAL (1.5 mg/kg), CLO (25 mg/kg), OLZ (2.5, 5 or 10 mg/kg) or ARI (2, 10 or 20 mg/kg), whereas control animals were given vehicle. BDNF and NGF levels were measured in rat hippocampus by sandwich-ELISA. The results showed that chronic administration of antipsychotics did not modify BDNF and NGF levels in rat hippocampus, suggesting that their therapeutic properties are not mediated by stimulation of these neurotrophins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Aloe L, Iannitelli A, Bersani G, Alleva E, Angelucci F, Maselli P, Manni L (1997) Haloperidol administration in humans lowers plasma nerve growth factor level: evidence that sedation induces opposite effects to arousal. Neuropsychobiology 36:65–68

    Article  PubMed  CAS  Google Scholar 

  • Angelucci F, Mathé AA, Aloe L (2000) Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration. J Neurosci Res 15:783–794

    Article  Google Scholar 

  • Angelucci F, Brené S, Mathé AA (2005) BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry 1:1–8

    Google Scholar 

  • Arnold SE, Trojanowski JQ, Gur RE, Blackwell P, Han LY, Choi C (1998) Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. Arch Gen Psychiatry 55:225–232

    Article  PubMed  CAS  Google Scholar 

  • Assis LC, Scaini G, Di-Pietro PB, Castro AA, Comim CM, Streck EL, Quevedo J (2007) Effect of antipsychotics on creatine kinase activity in rat brain. Basic Clin Pharmacol Toxicol 101:315–319

    Article  PubMed  CAS  Google Scholar 

  • Bagnall AM, Jones L, Ginnelly L, Lewis R, Glanville J, Gilbody S, Davies L, Torgerson D, Kleijnen J (2003) A systematic review of atypical antipsychotic drugs in schizophrenia. Health Technol Assess 7:1–193

    PubMed  Google Scholar 

  • Bai O, Chlan-Fourney J, Bowen R, Keegan D, Li XM (2003) Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. J Neurosci Res 71:127–131

    Article  PubMed  CAS  Google Scholar 

  • Bai O, Xu H, Li XM (2006) Haloperidol and atypical antipsychotics share a same action of decreasing P75(NTR) mRNA levels in PC12 cells. Life Sci 79:570–574

    Article  PubMed  CAS  Google Scholar 

  • Baldessarini RJ, Cole JO, Davis JM (1980) Tardive dyskinesia: a summary of a task force report of the American Psychiatric Association. Am J Psychiatry 137:1163–1172

    Google Scholar 

  • Bersani G, Iannitelli A, Maselli P, Pancheri P, Aloe L, Angelucci F, Alleva E (1999) Low nerve growth factor plasma levels in schizophrenic patients: a preliminary study. Schizophr Res 37:201–203

    PubMed  CAS  Google Scholar 

  • Buckley PF, Pillai A, Evans D, Stirewalt E, Mahadik S (2007) Brain derived neurotropic factor in first-episode psychosis. Schizophr Res 91:1–5

    Article  PubMed  Google Scholar 

  • DeVries AC, Joh HD, Bernard O, Hattori K, Hurn PD, Traystman RJ, Alkayed NJ (2001) Social stress exacerbates stroke outcome by suppressing Bcl-2 expression. Proc Natl Acad Sci U S A 98:11824–11828

    Article  PubMed  CAS  Google Scholar 

  • Durany N, Michel T, Zöchling R, Boissl KW, Cruz-Sánchez FF, Riederer P, Thome J (2001) Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr Res 52:79–86

    Article  PubMed  CAS  Google Scholar 

  • Ernfors P, Ibáñez CF, Ebendal T, Olson L, Persson H (1990) Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain. Proc Natl Acad Sci U S A 87:5454–5458

    Article  PubMed  CAS  Google Scholar 

  • Falkenberg T, Mohammed AK, Henriksson B, Persson H, Winblad B, Lindefors N (1992) Increased expression of brain-derived neurotrophic factor mRNA in rat hippocampus is associated with improved spatial memory and enriched environment. Neurosci Lett 138:153–156

    Article  PubMed  CAS  Google Scholar 

  • Gerlach J, Casey DE (1988) Tardive dyskinesia. Acta Psychiatr Scand 77:369–378

    Article  PubMed  CAS  Google Scholar 

  • Grillo RW, Ottoni GL, Leke R, Souza DO, Portela LV, Lara DR (2007) Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics. J Psychiatr Res 41:31–35

    Article  PubMed  Google Scholar 

  • Hashimoto T, Bergen SE, Nguyen QL, Xu B, Monteggia LM, Pierri JN, Sun Z, Sampson AR, Lewis DA (2005) Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J Neurosci 12:372–383

    Article  Google Scholar 

  • Heckers S (1997) Neuropathology of schizophrenia: cortex, thalamus, basal ganglia, and neurotransmitter-specific projection systems. Schizophr Bull 23:403–421

    PubMed  CAS  Google Scholar 

  • Honea R, Crow TJ, Passingham D, Mackay CE (2005) Regional deficits in brain volume in schizophrenia: a meta-analysis of voxelbased morphometry studies. Am J Psychiatry 162:2233–2245

    Article  PubMed  Google Scholar 

  • Kokaia Z, Bengzon J, Metsis M, Kokaia M, Persson H, Lindvall O (1993) Coexpression of neurotrophins and their receptors in neurons of the central nervous system. Proc Natl Acad Sci U S A 90:6711–6715

    Article  PubMed  CAS  Google Scholar 

  • Kovalchuk Y, Hanse E, Kafitz KW, Konnerth A (2002) Postsynaptic induction of BDNF-mediated long-term potentiation. Science 295:1729–1734

    Article  PubMed  CAS  Google Scholar 

  • Leibrock J, Lottspeich F, Hohn A, Hofer M, Hengerer B, Masiakowski P, Thoenen H, Barde YA (1989) Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341:149–152

    Article  PubMed  CAS  Google Scholar 

  • Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AI, Gur RE, McEvoy J, Perkins D, Hamer RM, Gu H, Tohen M, HGDH Study Group (2005) Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 62:361–370

    Article  PubMed  CAS  Google Scholar 

  • Lindén AM, Väisänen J, Lakso M, Nawa H, Wong G, Castrén E (2000) Expression of neurotrophins BDNF and NT-3, and their receptors in rat brain after administration of antipsychotic and psychotrophic agents. J Mol Neurosci 14:27–37

    Article  PubMed  Google Scholar 

  • Lipska BK, Khaing ZZ, Weickert CS, Weinberger DR (2001) BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs. Eur J Neurosci 14:135–144

    Article  PubMed  CAS  Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall RL (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–267

    PubMed  CAS  Google Scholar 

  • Lu B (2003) BDNF and activity-dependent synaptic modulation. Learn Mem 10:86–98

    Article  PubMed  Google Scholar 

  • Mizuno M, Yamada K, Takei N, Tran MH, He J, Nakajima A, Nawa H, Nabeshima T (2003) Phosphatidylinositol 3-kinase: a molecule mediating BDNF-dependent spatial memory formation. Mol Psychiatry 8:217–224

    Article  PubMed  CAS  Google Scholar 

  • Naber D, Karow A (2001) Good tolerability equals good results: the patient's perspective. Eur Neuropsychopharmacol 4:391–396

    Article  Google Scholar 

  • Pillai A, Terry AV Jr, Mahadik SP (2006) Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus. Schizophr Res 82:95–106

    Article  PubMed  Google Scholar 

  • Polydoro M, Schröder N, Lima MN, Caldana F, Laranja DC, Bromberg E, Roesler R, Quevedo J, Moreira JC, Dal-Pizzol F (2004) Haloperidol- and clozapine-induced oxidative stress in the rat brain. Pharmacol Biochem Behav 78:751–756

    Article  PubMed  CAS  Google Scholar 

  • Reinke A, Martins MR, Lima MS, Moreira JC, Dal-Pizzol F, Quevedo J (2004) Haloperidol and clozapine, but not olanzapine, induces oxidative stress in rat brain. Neurosci Lett 372:157–160

    Article  PubMed  CAS  Google Scholar 

  • Scaccianoce S, Del Bianco P, Caricasole A, Nicoletti F, Catalani A (2003) Relationship between learning, stress and hippocampal brain-derived neurotrophic factor. Neuroscience 121:825–828

    Article  PubMed  CAS  Google Scholar 

  • Selemon LD, Rajkowska G, Goldman-Rakic PS (1995) Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry 52:805–818

    PubMed  CAS  Google Scholar 

  • Shao Z, Dyck LE, Wang H, Li XM (2006) Antipsychotic drugs cause glial cell line-derived neurotrophic factor secretion from C6 glioma cells. J Psychiatry Neurosci 31:32–37

    PubMed  Google Scholar 

  • Streck EL, Rezin GT, Barbosa LM, Assis LC, Grandi E, Quevedo J (2007) Effect of antipsychotics on succinate dehydrogenase and cytochrome oxidase activities in rat brain. Naunyn Schmiedebergs Arch Pharmacol 376:127–133

    Article  PubMed  CAS  Google Scholar 

  • Thoenen H (1995) Neurotrophins and neuronal plasticity. Science 270:593–598

    Article  PubMed  CAS  Google Scholar 

  • Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660–669

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This research was supported by grants from Eli Lilly do Brazil, Universidade do Extremo Sul Catarinense (UNESC) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to João Quevedo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Valvassori, S.S., Stertz, L., Andreazza, A.C. et al. Lack of effect of antipsychotics on BNDF and NGF levels in hippocampus of Wistar rats. Metab Brain Dis 23, 213–219 (2008). https://doi.org/10.1007/s11011-008-9083-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-008-9083-8

Keywords

Navigation